Methylprednisolone and Oral mucosal blistering - a phase IV clinical study of FDA data

Summary:

Oral mucosal blistering is reported as a side effect among people who take Methylprednisolone (methylprednisolone), especially for people who are female, 20-29 old, also take Acetaminophen, and have Pemphigus.

The phase IV clinical study analyzes which people have Oral mucosal blistering when taking Methylprednisolone. It is created by eHealthMe based on reports of 58,374 people who have side effects when taking Methylprednisolone from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Oral mucosal blistering?

Oral mucosal blistering (mouth ulcer) is found to be associated with 552 drugs and 652 conditions by eHealthMe. Check the latest studies of Oral mucosal blistering.

On Jul, 04, 2026

58,374 people reported to have side effects when taking Methylprednisolone.
Among them, 18 people (0.03%) have Oral mucosal blistering.

Could Methylprednisolone cause Oral mucosal blistering?

Among these 18 people:

What is the gender of people who have Oral mucosal blistering when taking Methylprednisolone? *

female: 72.73 %
male: 27.27 %

What is the age of people who have Oral mucosal blistering when taking Methylprednisolone? *

What are other drugs people take besides Methylprednisolone? *

Acetaminophen: 17 people, 94.44%
Diphenhydramine Hydrochloride: 16 people, 88.89%
Prednisone: 16 people, 88.89%
Azathioprine: 9 people, 50.00%
Risedronate Sodium: 7 people, 38.89%
Methotrexate: 7 people, 38.89%
Mycophenolate Mofetil: 7 people, 38.89%
Morphine: 6 people, 33.33%
Acyclovir: 6 people, 33.33%
Celebrex: 6 people, 33.33%

What are other side effects people have besides Oral mucosal blistering? *

Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 15 people, 83.33%
Rash Vesicular (rash with a small bubble): 7 people, 38.89%
Weight Increased: 7 people, 38.89%
Meibomian Gland Dysfunction (dry eyes): 7 people, 38.89%
White Blood Cell Count Decreased: 6 people, 33.33%
Pain: 6 people, 33.33%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 33.33%
Blood Pressure Fluctuation: 6 people, 33.33%
Body Temperature Increased: 6 people, 33.33%
Canker Sores (painful, open sore in the mouth): 6 people, 33.33%

What are the existing conditions these people have? *

Pemphigus (any of several acute or chronic skin diseases characterized by groups of itching blisters): 17 people, 94.44%
Pemphigoid (tense blisters on the skin): 6 people, 33.33%
Joint Pain: 6 people, 33.33%
Pharyngitis (inflammation of the pharynx, causing a sore throat): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and have Oral mucosal blistering?

- Check whether Oral mucosal blistering is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methylprednisolone:

Methylprednisolone (59,645 reports)

Browse all side effects of Methylprednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oral mucosal blistering:

Oral mucosal blistering (552 drugs)

Browse all the conditions that are associated with Oral mucosal blistering:

Oral mucosal blistering (652 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone (the active ingredients of Methylprednisolone) and Methylprednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.